Effects of tyrosine kinase inhibitor-masitinib mesylate on canine mammary tumour cell lines

• Autorzy: Ustun-Alkan F. , Bakirel T. , Ustuner O. , Anlas C. , Cinar S. , Yildirim F. , Gurel A.
• Języki publikacji: EN

Abstrakty

EN

Słowa kluczowe

EN

tyrosine kinase inhibitor; masitinib; mast cell tumour; dog; treatment; antiproliferative effect; canine mammary cancer; apoptosis; vascular endothelial growth factor

• Wydawca: -
• Czasopismo: Journal of Veterinary Research
• Rocznik: 2021
• Tom: 65
• Numer: 3
• Opis fizyczny: p.351-359,fig.,ref.

Twórcy

autor

Ustun-Alkan F.

• Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Istanbul University-Cerrahpasa, 34500, Istanbul, Turkey

autor

Bakirel T.

• Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Istanbul University-Cerrahpasa, 34500, Istanbul, Turkey

autor

Ustuner O.

• Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Istanbul University-Cerrahpasa, 34500, Istanbul, Turkey

autor

Anlas C.

• Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Istanbul University-Cerrahpasa, 34500, Istanbul, Turkey

autor

Cinar S.

• Department of Immunology, Aziz Sancar Institute of Experimental Medicine, Istanbul University, 34093, Istanbul, Turkey

autor

Yildirim F.

• Department of Pathology, Istanbul University, 34093, Istanbul, Turkey

autor

Gurel A.

• Department of Pathology, Istanbul University, 34093, Istanbul, Turkey

Identyfikatory

DOI

10.2478/jvetres-2021-042